This was the stock's fourth consecutive day of gains.

Explore the latest news on 23andMe as a U.S. judge approves its sale amid privacy concerns and consumer issues.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines.

Star Wars: Zero Company to Be Officially Revealed From Respawn and Bit Reactor This Weekend On a panel not so far far away.

A $44 billion purchase by Elon Musk saw Twitter rebranded to X and all old memorabilia like the iconic blue bird logo nicknamed Larry eventually auctioned off. An online marketplace company bought ...

Fabian Muhly is Partner at Leo & Muhly Cyber Advisory and founder of DRMUHLY, an initiative promoting cyber risk resilience through wellbeing. Holding a PhD in criminology, his consulting and ...

A company logo is not only visually appealing in today's digital marketing era, but also serves as a cohesive brand identity. A well-crafted logo on marketing materials can make a strong impression in ...

Anne Wojcicki, former chief executive of 23andMe, won a bid to acquire the genetic testing company she founded in a second auction.

The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against Regeneron Pharmaceuticals Inc.

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to a nonprofit led by the company’s co-founder and former CEO, Anne Wojcicki.